Kepivance Related Clinical Trials
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma [Completed]
Palifermin DDI (Drug Drug Interaction) [Completed]
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma [Completed]
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer [Active, not recruiting]
Palifermin After Haploidentical PBSCT [Withdrawn]
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Completed]
Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant [Withdrawn]
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) [Completed]
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [Completed]
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [Completed]
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation [Completed]
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support [Completed]
Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults [Completed]
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy [Withdrawn]
Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis [Recruiting]
Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation [Not yet recruiting]
Study to Characterize the Effect of Heparin on Palifermin Activity [Completed]
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer [Completed]
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy [Active, not recruiting]
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer [Active, not recruiting]
Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis [Recruiting]
Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma [Completed]
Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation [Terminated]
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Recruiting]
Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) [Active, not recruiting]
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer [Terminated]
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Recruiting]
PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation [Completed]
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma [Not yet recruiting]
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma [Withdrawn]
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies [Active, not recruiting]
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants [Completed]
Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy [Completed]
Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies [Recruiting]
High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma [Active, not recruiting]
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma [Terminated]
High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease [Active, not recruiting]
Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD [Terminated]
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Completed]
A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients [Recruiting]
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer [Completed]
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer [Completed]
Keratinocyte Growth Factor to Prevent Acute GVHD [Completed]
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Recruiting]
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) [Recruiting]
A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation [Completed]
A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation [Not yet recruiting]
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Active, not recruiting]
Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) [Completed]
|